Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCs for Chronic Wounds
NCT02092870Phase 2Completed
- Sponsor
- Tower Outpatient Surgery Center
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose derived mesenchymal stromal cells in Chronic wound, diabetic foot disease (DFD), venous ulcer, pressure ulcer, sponsored by Tower Outpatient Surgery Center. Started Sep 2013; status: completed.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
Chronic wounddiabetic foot disease (DFD)venous ulcerpressure ulcer
Beyond the preview
Go deeper on NCT02092870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092870.